Plasma cholesteryl ester transfer protein and blood coagulabilityDEGUCHI, Hiroshi; FERNANDEZ, José A; GRIFFIN, John H et al.Thrombosis and haemostasis. 2007, Vol 98, Num 6, pp 1160-1164, issn 0340-6245, 5 p.Article

Cytoprotective protein C pathways and implications for stroke and neurological disordersZLOKOVIC, Berislav V; GRIFFIN, John H.Trends in neurosciences (Regular edition). 2011, Vol 34, Num 4, pp 198-209, issn 0166-2236, 12 p.Article

EnantiotracinMCDOUGAL, Patrick G; GRIFFIN, John H.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 13, pp 2239-2240, issn 0960-894X, 2 p.Article

Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivationRINTELEN, Claudia; YEGNESWARAN, Subramanian; GRIFFIN, John H et al.Thrombosis and haemostasis. 2001, Vol 85, Num 2, pp 274-279, issn 0340-6245Article

Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1YAOMING WANG; ZHEN ZHAO; CHOW, Nienwen et al.Brain research. 2013, Vol 1507, pp 97-104, issn 0006-8993, 8 p.Article

Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein CYEGNESWARAN, Subramanian; NGUYEN, Phuong M; GALE, Andrew J et al.Thrombosis and haemostasis. 2009, Vol 101, Num 1, pp 55-61, issn 0340-6245, 7 p.Article

Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimersGRIFFIN, John H; LINSELL, Martin S; JENKINS, Thomas E et al.Journal of the American Chemical Society. 2003, Vol 125, Num 21, pp 6517-6531, issn 0002-7863, 15 p.Article

Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult VolunteersLYDEN, Patrick; LEVY, Howard; WEYMER, Sara et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 42, pp 7479-7485, issn 1381-6128, 7 p.Article

Infrared fluorescence for vascular barrier breach in vivo ―A novel method for quantitation of albumin effluxVON DRYGALSKI, Annette; FURLAN-FREGUIA, Christian; MOSNIER, Laurent O et al.Thrombosis and haemostasis. 2012, Vol 108, Num 5, pp 987-997, issn 0340-6245, 11 p.Article

Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primatesGRUBER, Andras; MARZEC, Ulla M; BUSH, Leslie et al.Blood. 2007, Vol 109, Num 9, pp 3733-3740, issn 0006-4971, 8 p.Article

The cytoprotective protein C pathwayMOSNIER, Laurent O; ZLOKOVIC, Berislav V; GRIFFIN, John H et al.Blood. 2007, Vol 109, Num 8, pp 3161-3172, issn 0006-4971, 12 p.Article

Functional recovery after embolic stroke in rodents by activated protein CZLOKOVIC, Berislav V; CHUNLING ZHANG; DONG LIU et al.Annals of neurology. 2005, Vol 58, Num 3, pp 474-477, issn 0364-5134, 4 p.Article

Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathwayDEGUCHI, Hiroshi; FERNANDEZ, José A; PABINGER, Ingrid et al.Blood. 2001, Vol 97, Num 7, pp 1907-1914, issn 0006-4971Article

Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitorsBUCKNER, Frederick S; GRIFFIN, John H; WILSON, Aaron J et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 4, pp 1210-1215, issn 0066-4804Article

Cytoprotective-selective activated protein C therapy for ischaemic stroke : Coagulation proteases and cardiovascular diseaseMOSNIER, Laurent O; ZLOKOVIC, Berislav V; GRIFFIN, John H et al.Thrombosis and haemostasis. 2014, Vol 112, Num 5, pp 883-892, issn 0340-6245, 10 p.Article

Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic StrokeWILLIAMS, Patricia D; ZLOKOVIC, Berislav V; GRIFFIN, John H et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 27, pp 4215-4222, issn 1381-6128, 8 p.Article

Human Thrombomodulin Knock-In Mice Reveal Differential Effects of Human Thrombomodulin on Thrombosis and AtherosclerosisRAIFE, Thomas J; DWYRE, Denis M; MAEDA, Nobuyo et al.Arteriosclerosis, thrombosis, and vascular biology. 2011, Vol 31, Num 11, pp 2509-2517, issn 1079-5642, 9 p.Article

Elevated plasma fibronectin levels associated with venous thromboembolismPECHENIUK, Natalie M; ELIAS, Darlene J; DEGUCHI, Hiroshi et al.Thrombosis and haemostasis. 2008, Vol 100, Num 2, pp 224-228, issn 0340-6245, 5 p.Article

A novel ELISA for mouse activated protein C in plasmaFERNANDEZ, José A; LENTZ, Steven R; DWYRE, Denis M et al.Journal of immunological methods. 2006, Vol 314, Num 1-2, pp 174-181, issn 0022-1759, 8 p.Article

Graft protein C entrapment is associated with reduced phagocyte activation during reperfusion in human liver transplantationILMAKUNNAS, Minna; PESONEN, Eero J; HÖCKERSTEDT, Krister et al.Critical care medicine. 2006, Vol 34, Num 2, pp 426-432, issn 0090-3493, 7 p.Article

High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in menDEGUCHI, Hiroshi; PECHENIUK, Natalie M; ELIAS, Darlene J et al.Circulation (New York, N.Y.). 2005, Vol 112, Num 6, pp 893-899, issn 0009-7322, 7 p.Article

Activated protein C variants with normal cytoprotective but reduced anticoagulant activityMOSNIER, Laurent O; GALE, Andrew J; YEGNESWARAN, Subramanian et al.Blood. 2004, Vol 104, Num 6, pp 1740-1744, issn 0006-4971, 5 p.Article

Protein S confers neuronal protection during ischemic/hypoxic injury in miceDONG LIU; HUANG GUO; GRIFFIN, John H et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 13, pp 1791-1796, issn 0009-7322, 6 p.Article

Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulationHEEB, Mary J; MESTERS, Rolf M; FERNANDEZ, José A et al.Thrombosis and haemostasis. 2013, Vol 110, Num 2, pp 275-282, issn 0340-6245, 8 p.Article

Protein C anticoagulant and cytoprotective pathways : PIH: Current understanding of thrombosis and hemostasis-from bench to bedsideGRIFFIN, John H; ZLOKOVIC, Berislav V; MOSNIER, Laurent O et al.International journal of hematology. 2012, Vol 95, Num 4, pp 333-345, issn 0925-5710, 13 p.Conference Paper